Literature DB >> 9400999

Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas.

V Shridhar1, Q C Sun, O J Miller, G P Kalemkerian, J Petros, D I Smith.   

Abstract

Cytogenetic and molecular analysis of DNA sequences with highly polymorphic microsatellite markers have implicated allele loss in several chromosomal regions including 3p, 6p, 6q, 8p, 9p, 9q, 11p and 14q in the pathogenesis of sporadic renal cell carcinomas (RCCs). Deletions involving the long arm of chromosome 7 have not been described in RCCs although they have been seen in several other tumor types. However, there have been no detailed analysis of loss of heterozygosity (LOH) of 7q sequences in sporadic RCCs. We therefore studied LOH for DNA sequences on 7q with 10 highly polymorphic markers in 92 matched normal/tumor samples representing sporadic RCCs including papillary, nonpapillary, and oncocytomas in order to determine whether allelic loss could be detected in a tumor type with no visible 7q rearrangements at the cytogenetic level. We found chromosome 7q allele loss in 59 of 92 cases (64%) involving one, two, or more microsatellite markers. The most common allele loss included loci D7S522 (24%) and D7S649 (30%) at 7q31.1-31.2, a region that contains one of the common fragile sites, FRA7G. By comparative multiplex PCR analysis, we detected a homozygous deletion of one marker in the 7q 31.1-31.2 region in one tumor, RC21. These results support the idea that a tumor suppressor gene in 7q31 is involved in the pathogenesis of sporadic renal cell carcinomas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9400999     DOI: 10.1038/sj.onc.1201448

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

1.  Construction of a high-resolution physical map of the approximate 1-Mb region of human chromosome 7q31.1-q31.2 harboring a putative tumor suppressor gene.

Authors:  J C Zenklusen; L A Weintraub; E D Green
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

2.  Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status.

Authors:  Tianhong Li; Federica Sotgia; Magalis A Vuolo; Maomi Li; Wan Cai Yang; Richard G Pestell; Joseph A Sparano; Michael P Lisanti
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

3.  Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas.

Authors:  K Wiechen; C Sers; A Agoulnik; K Arlt; M Dietel; P M Schlag; U Schneider
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

4.  Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene.

Authors:  K Wiechen; L Diatchenko; A Agoulnik; K M Scharff; H Schober; K Arlt; B Zhumabayeva; P D Siebert; M Dietel; R Schäfer; C Sers
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

5.  7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma.

Authors:  M Mateo; M Mollejo; R Villuendas; P Algara; M Sanchez-Beato; P Martínez; M A Piris
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

6.  Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade.

Authors:  F Galbiati; D Volonte; J A Engelman; G Watanabe; R Burk; R G Pestell; M P Lisanti
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

7.  Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells.

Authors:  Caterina Bianco; Luigi Strizzi; Mario Mancino; Kazuhide Watanabe; Monica Gonzales; Shin Hamada; Ahmed Raafat; Lawson Sahlah; Cindy Chang; Federica Sotgia; Nicola Normanno; Michael Lisanti; David S Salomon
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

8.  Mutations in the ST7/RAY1/HELG locus rarely occur in primary colorectal, gastric, and hepatocellular carcinomas.

Authors:  S Yoshimura; T Yamada; S Ohwada; T Koyama; K Hamada; K Tago; I Sakamoto; I Takeyoshi; T Ikeya; F Makita; Y Iino; Y Morishita
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

9.  Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation.

Authors:  Franco Capozza; Terence M Williams; William Schubert; Steve McClain; Boumediene Bouzahzah; Federica Sotgia; Michael P Lisanti
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

10.  Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia.

Authors:  Hyangkyu Lee; David S Park; Babak Razani; Robert G Russell; Richard G Pestell; Michael P Lisanti
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.